S&P Global Ratings has upgraded the credit rating of Alvogen Pharma US Inc. to ’CCC+’ from ’SD’ (selective default) following the successful completion of a debt restructuring transaction. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback